Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Compounds used to enhance the contrast of magnetic resonance imaging (MRI) by altering the relaxation times of water protons, thus improving the visibility of different tissues in medical imaging. Common MRI contrast agents include gadolinium-based compounds, manganese-based agents, and superparamagnetic iron oxide particles. These agents are administered via injection or orally, depending on the application. They are essential for diagnostic imaging, particularly in detecting abnormalities in various tissues.
Shorten T1 and/or T2 relaxation times of water protons, enhancing contrast in MRI images.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Imaging contrast for magnetic resonance imaging (MRI contrast agents).